FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma
Open Access
- 25 April 2022
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 544
Abstract
The standard of care for isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM) is maximal resection followed by chemotherapy and radiation. Studies investigating the resection of GBM have primarily focused on the contrast enhancing portion of the tumor on magnetic resonance imaging. Histopathological studies, however, have demonstrated tumor infiltration within peri-tumoral fluid-attenuated inversion recovery (FLAIR) abnormalities, which is often not resected. The histopathology of FLAIR and local recurrence patterns of GBM have prompted interest in the resection of peri-tumoral FLAIR, or FLAIRectomy. To this point, recent studies have suggested a significant survival benefit associated with safe peri-tumoral FLAIR resection. In this review, we discuss the evidence surrounding the composition of peri-tumoral FLAIR, outcomes associated with FLAIRectomy, future directions of the field, and potential implications for patients.Keywords
This publication has 70 references indexed in Scilit:
- Classifying Human Brain Tumors by Lipid Imaging with Mass SpectrometryCancer Research, 2012
- Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective StudyPLOS ONE, 2011
- An extent of resection threshold for newly diagnosed glioblastomasJournal of Neurosurgery, 2011
- Intraoperative Confocal Microscopy for Brain Tumors: A Feasibility Analysis in HumansOperative Neurosurgery, 2011
- Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy StudyAmerican Journal of Neuroradiology, 2010
- Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimagingBrain Tumor Pathology, 2010
- Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation StatusJournal of Clinical Oncology, 2009
- Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic BiopsiesAmerican Journal of Neuroradiology, 2007
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005